XB
XTL Biopharmaceuticals Ltd ADR
🇺🇸XNAS.XTLBUnited StatesHealthcare
$2.50USDup +0.07 (+2.88%)ClosedEnd of day11:02 PM
Price$2.50+0.07 (+2.88%)
Profile
- Healthcare
- Biotechnology
- United States
Identity
- Exchange
- Nasdaq . XNAS
- Type
- Stock
- ISIN
- US98386D4060
- CUSIP
- 98386D307
Company
- Employees
- 4
- Headquarters
- Herzliya, United States
- Website
- https://www.xtlbio.com
- CEO
- Mr. Noam Band
Market
- Shares outstanding
- 2.5M
- Market cap
- $6.14M
Highlights
- Market cap
- $6.14M
- EPS LTM
- -$4.01
- P/E LTM
- -0.30
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $740K+100%up year on year
- Net income
- -$1.77M-1,774.12%down year on year
- Gross margin
- -5.41%
- Free cash flow
- Not reported
Other listings
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.